Sheng Yun

439 total citations
16 papers, 336 citations indexed

About

Sheng Yun is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Sheng Yun has authored 16 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Sheng Yun's work include Mesenchymal stem cell research (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Tissue Engineering and Regenerative Medicine (2 papers). Sheng Yun is often cited by papers focused on Mesenchymal stem cell research (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Tissue Engineering and Regenerative Medicine (2 papers). Sheng Yun collaborates with scholars based in China, United Kingdom and United States. Sheng Yun's co-authors include Marina Botto, Joseph J. Boyle, Dorian O. Haskard, Vinay K. Bhatia, G. Martin Benson, David C. Grimsditch, Hanyu Yang, Xiaodong Liu, Liang Zhu and Ying Qiu and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, American Journal Of Pathology and BioMed Research International.

In The Last Decade

Sheng Yun

16 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheng Yun China 11 199 75 64 41 36 16 336
Ekaterina Zezina Germany 10 113 0.6× 123 1.6× 32 0.5× 51 1.2× 27 0.8× 12 309
Aihiro Yamamoto Japan 11 211 1.1× 136 1.8× 26 0.4× 29 0.7× 56 1.6× 31 429
Zaki Al‐Yafeai United States 9 106 0.5× 164 2.2× 39 0.6× 35 0.9× 18 0.5× 18 369
Fereshte Abdolmaleki Iran 6 169 0.8× 95 1.3× 51 0.8× 43 1.0× 23 0.6× 11 313
T. Tataranni Italy 10 88 0.4× 116 1.5× 36 0.6× 23 0.6× 15 0.4× 12 342
Fengxia He China 11 128 0.6× 148 2.0× 27 0.4× 27 0.7× 24 0.7× 19 346
Heather L. Van Sweringen United States 6 177 0.9× 94 1.3× 130 2.0× 56 1.4× 17 0.5× 7 375
Mathias Drach Austria 11 141 0.7× 144 1.9× 32 0.5× 60 1.5× 19 0.5× 18 344
Yuzhen Wei China 11 150 0.8× 130 1.7× 34 0.5× 28 0.7× 19 0.5× 14 347
Raquel Roldán-Montero Spain 9 139 0.7× 117 1.6× 74 1.2× 26 0.6× 29 0.8× 13 388

Countries citing papers authored by Sheng Yun

Since Specialization
Citations

This map shows the geographic impact of Sheng Yun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Yun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Yun more than expected).

Fields of papers citing papers by Sheng Yun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng Yun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Yun. The network helps show where Sheng Yun may publish in the future.

Co-authorship network of co-authors of Sheng Yun

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng Yun. A scholar is included among the top collaborators of Sheng Yun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng Yun. Sheng Yun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Yang, Hanyu, Mengxiang Su, Sheng Yun, et al.. (2023). Hepatic retinaldehyde deficiency is involved in diabetes deterioration by enhancing PCK1- and G6PC-mediated gluconeogenesis. Acta Pharmaceutica Sinica B. 13(9). 3728–3743. 15 indexed citations
2.
3.
Yang, Hanyu, Linjun You, Zhongyan Wang, et al.. (2023). Bile duct ligation elevates 5-HT levels in cerebral cortex of rats partly due to impairment of brain UGT1A6 expression and activity via ammonia accumulation. Redox Biology. 69. 103019–103019. 8 indexed citations
4.
Yun, Sheng, Hanyu Yang, Tong Wu, et al.. (2021). Alterations of Cytochrome P450s and UDP-Glucuronosyltransferases in Brain Under Diseases and Their Clinical Significances. Frontiers in Pharmacology. 12. 650027–650027. 17 indexed citations
5.
Wu, Tong, Sheng Yun, Yuanyuan Qin, et al.. (2021). Bile duct ligation causes opposite impacts on the expression and function of BCRP and P-gp in rat brain partly via affecting membrane expression of ezrin/radixin/moesin proteins. Acta Pharmacologica Sinica. 42(11). 1942–1950. 14 indexed citations
6.
Zhu, Liang, Feng Xu, Hanyu Yang, et al.. (2021). Hepatic Ischemia-Reperfusion Impairs Blood-Brain Barrier Partly Due to Release of Arginase From Injured Liver. Frontiers in Pharmacology. 12. 724471–724471. 12 indexed citations
7.
Yang, Hanyu, Ming Liu, Sheng Yun, et al.. (2021). All-trans retinoic acid impairs glucose-stimulated insulin secretion by activating the RXR/SREBP-1c/UCP2 pathway. Acta Pharmacologica Sinica. 43(6). 1441–1452. 10 indexed citations
8.
Qiu, Ying, et al.. (2017). Digital gene expression profiling of dendritic cells treated with Seabuckthorn favones. Zhonghua weishengwuxue he mianyixue zazhi. 37(11). 840–848. 1 indexed citations
9.
10.
11.
Qiu, Ying, et al.. (2014). Human umbilical cord mesenchymal stromal cells suppress MHC class II expression on rat vascular endothelium and prolong survival time of cardiac allograft.. Europe PMC (PubMed Central). 14 indexed citations
12.
Qiu, Ying, et al.. (2012). Pancreatic carcinoma-specific immunotherapy using synthesised alpha-galactosyl epitope-activated immune responders: findings from a pilot study. International Journal of Clinical Oncology. 18(4). 657–665. 23 indexed citations
13.
Yun, Sheng, Marina Botto, Justin C. Mason, et al.. (2009). Decay-Accelerating Factor Suppresses Complement C3 Activation and Retards Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice. American Journal Of Pathology. 175(4). 1757–1767. 38 indexed citations
14.
Yun, Sheng, et al.. (2008). Brief Report: Accelerated Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice Lacking the Membrane-Bound Complement Regulator CD59. Arteriosclerosis Thrombosis and Vascular Biology. 28(10). 1714–1716. 33 indexed citations
15.
Bhatia, Vinay K., Sheng Yun, David C. Grimsditch, et al.. (2007). Complement C1q Reduces Early Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice. American Journal Of Pathology. 170(1). 416–426. 127 indexed citations
16.
Su, Xiulan, et al.. (2004). Population studies on two native Mongolian population groups in China using STR loci. Forensic Science International. 141(2-3). 197–199. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ekaterina Zezina Breakdown of academic impact, for papers by Aihiro Yamamoto Breakdown of academic impact, for papers by Zaki Al‐Yafeai Breakdown of academic impact, for papers by Fereshte Abdolmaleki Breakdown of academic impact, for papers by T. Tataranni Breakdown of academic impact, for papers by Fengxia He Breakdown of academic impact, for papers by Heather L. Van Sweringen Breakdown of academic impact, for papers by Mathias Drach Breakdown of academic impact, for papers by Yuzhen Wei Breakdown of academic impact, for papers by Raquel Roldán-Montero
Rankless by CCL
2026